Arizona’s harm reduction funding stack just got more brittle — and more local

The April 24 SAMHSA letter changes who pays — not what is allowed. For Arizona, that distinction matters because the state’s harm-reduction infrastructure already runs on a stack of overlapping funding sources, several of which are not federal.

The pieces still funded the same way as last week: the state share of the opioid settlement ($526M over 18 years), the Maricopa County share ($669M, with a recent first payment of $4.7M and ongoing disbursements through county and contracted providers), AHCCCS’s $776M annual SUD allocation, and the Hikma settlement naloxone shipment of 13,198 doses arriving September 2026.

The pieces newly exposed: any AZ-based harm-reduction program that buys fentanyl, xylazine, or medetomidine test strips, sterile syringes, or sterile water through SAMHSA pass-through dollars (typically the State Opioid Response grant) now needs to swap that line item to settlement, county, or philanthropic funding. Same supplies. Different invoice.

What that means in practice

In a county like Maricopa — where fentanyl was involved in 59% of 2024 fatal overdoses and meth in 67% (with substantial overlap) — the local infrastructure to fund a swap is largely in place. Maricopa County has been actively deploying settlement dollars across MAT-in-jail, prevention contracts, and 17 community organizations from the April 2025 first round. A SAMHSA-to-settlement swap for test strip purchasing is administratively painful but financially feasible.

In smaller AZ counties without active settlement disbursement infrastructure, the swap is harder. SAMHSA SOR pass-throughs have been the operating capital for a lot of those programs. State-level conversations between AHCCCS, AZDHS, and the Attorney General’s office about a centralized harm-reduction supply stream — naloxone, strips, sterile supplies, all on one bulk-purchase line — would meaningfully de-risk the next 18 months.

What to watch

Three signals worth tracking in the next 30 to 60 days:

The Maricopa County 2025 overdose data drop, expected late Q2 or early Q3. If 2025 shows the same pace of national decline (~16%), Arizona will have evidence that the current stack is working — making the case for protecting it stronger.

AHCCCS guidance to its managed care plans about coverage of harm-reduction supplies through plan benefit dollars rather than grant dollars. Several AZ MCOs already cover naloxone; expansion to test strips and other items is technically possible.

Application activity into the Maricopa County and AZ Attorney General settlement pools for harm-reduction-specific use cases. The pool is funded; the pull side is what determines speed.

Why this matters for people in recovery

For a person in recovery, what changed last week is not whether harm-reduction supplies will be available in Arizona — they will be. What changed is which programs are stable enough to be the place you tell a friend to go. If your local syringe service program quietly closes in the next six months, this is the cause. If a new county distribution point opens in the next six months, this is also the cause. The supply chain is reorganizing in real time.

If you need test strips, sterile supplies, or naloxone in Arizona today, 211 Arizona and your county public health department are the fastest current routes.

---

If you or someone you love is in immediate danger, call or text 988 or 911. If a loved one may be experiencing an overdose, call 911 and use naloxone if available.